Mark Sard

Director/Board Member at LIRUM THERAPEUTICS, INC.

61 year

Health Technology

Consumer Services

Finance

Profile

Mark Sard is the founder.
He founded Frontier Equities VC LLC in 2011 as a Principal.
He is currently working as a Director at Lirum Therapeutics, Inc. since 2022.
Previously, he worked as a Director at Stemline Therapeutics, Inc. from 2018 to 2020.
Mr. Sard completed his undergraduate degree at the University of Pennsylvania.

Mark Sard active positions

Companies	Position	Start
LIRUM THERAPEUTICS, INC.	Director/Board Member	31/10/2022
Frontier Equities VC LLC Frontier Equities VC LLC Investment ManagersFinance Frontier Equities seeks investment opportunities in early to mid-stage companies located in United States. The firm focuses across a wide array of sectors.	Founder	31/12/2010

All active positions of Mark Sard

Former positions of Mark Sard

Companies	Position	End
STEMLINE THERAPEUTICS, INC.	Director/Board Member	09/06/2020

See the detail of Mark Sard's experience

Training of Mark Sard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Sard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Stemline Therapeutics, Inc. Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Frontier Equities VC LLC Frontier Equities VC LLC Investment ManagersFinance Frontier Equities seeks investment opportunities in early to mid-stage companies located in United States. The firm focuses across a wide array of sectors.	Finance
Lirum Therapeutics, Inc. Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases	Health Technology

See company connections